← Back to Search

Dynavision D2 for Traumatic Brain Injury

N/A

Recruiting

Research Sponsored by Queen's University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up ~5-6 weeks from baseline

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare the effects of using the Dynavision D2 tool to improve left neglect in adults with brain injury, versus usual OT treatment.

Who is the study for?

This trial is for adults with brain injuries who have moderate to severe left neglect, as determined by the Catherine Bergego Scale. Participants must be motivated and able to handle up to three hours of daily therapy including Occupational Therapy, Physiotherapy, and Speech Therapy. They should be inpatients on stroke or acute brain injury services at Providence Care Hospital.

What is being tested?

The study tests if the Dynavision D2 device can help improve spatial awareness and daily activity performance in those with brain injuries. It's a randomized control trial where some get usual occupational therapy (OT) while others combine OT with sessions using Dynavision D2.

What are the potential side effects?

Since this trial involves a non-invasive therapeutic device rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during rehabilitation exercises.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ ~5-6 weeks from baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~~5-6 weeks from baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and ~5-6 weeks from baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Mean change from baseline score on Catherine Bergego Scale after 10 therapy sessions

Mean change from baseline score on Catherine Bergego Scale after 20 therapy sessions

Secondary study objectives

Mean change from baseline score on Letter Cancellation Test after 10 therapy sessions

Mean change from baseline score on Letter Cancellation Test after 20 therapy sessions

Mean change from baseline score on Star Cancellation Test after 10 therapy sessions

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Repetitive Visual Scanning TrainingExperimental Treatment1 Intervention

Participants will receive 30 minutes of their usual occupational therapy treatment and a 30 minute session of the Dynavision for 10 sessions for short stay inpatients (\~ 3 weeks) and 20 sessions for clients with longer 5-6 week stay.

Group II: Usual TreatmentActive Control1 Intervention

Participants will receive the standard 60 minutes of occupational therapy treatment.

Do I qualify?Apply below to find out